Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05217472
What this trial is testing

An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)

Who this might be right for
Sjogren's Syndrome (SS)
AbbVie
Testing effectiveness (Phase 2)Study completedNCT00425932
What this trial is testing

Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gaylis, Norman B., M.D. 60
Testing effectiveness (Phase 2)Ended earlyNCT02393378
What this trial is testing

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Takeda 7
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Testing effectiveness (Phase 2)Study completedNCT00077870
What this trial is testing

Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 237
Testing effectiveness (Phase 2)Study completedNCT00243412
What this trial is testing

The Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 42
Early research (Phase 1)Looking for participantsNCT06917742
What this trial is testing

Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE)

Who this might be right for
Healthy VolunteersRheumatoid ArthritisSystemic Lupus Erythematosus
Capstan Therapeutics 64
Early research (Phase 1)Ended earlyNCT03161457
What this trial is testing

JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, Rheumatoid
JHL Biotech, Inc. 153
Not applicableStudy completedNCT01741688
What this trial is testing

An Observational Study of Tocilizumab (Actemra) in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 16
Testing effectiveness (Phase 2)Ended earlyNCT04035668
What this trial is testing

Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

Who this might be right for
Sjögren Syndrome
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT02706847
What this trial is testing

Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
AbbVie 499
Testing effectiveness (Phase 2)Ended earlyNCT07100938
What this trial is testing

A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
BeiGene 49
Testing effectiveness (Phase 2)Study completedNCT03028467
What this trial is testing

Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 15
Large-scale testing (Phase 3)Study completedNCT00754572
What this trial is testing

Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 418
Testing effectiveness (Phase 2)Active Not RecruitingNCT07233655
What this trial is testing

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Large-scale testing (Phase 3)Study completedNCT03522415
What this trial is testing

Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Moderately to Severely Active Rheumatoid Arthritis
Shanghai Henlius Biotech 275
Testing effectiveness (Phase 2)Study completedNCT00642629
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate, Administered to Patients With Rheumatoid Arthritis to Determine Safety, Tolerability, Pharmacokinetic and Synovial Tissue Outcomes

Who this might be right for
Active, Moderate to Severe Rheumatoid Arthritis
Synta Pharmaceuticals Corp. 35
Large-scale testing (Phase 3)Study completedNCT00106522
What this trial is testing

Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 499
Not applicableStudy completedNCT02608112
What this trial is testing

Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Large-scale testing (Phase 3)Study completedNCT02293902
What this trial is testing

A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)

Who this might be right for
Rheumatoid Arthritis
Sanofi 243
Next Page